Abstract:BACKGROUND: Innate immune responses are fine-tuned by small noncoding RNA molecules termed microRNAs (miRs) that modify gene expression in response to the environment. During acute infections, miRs can be secreted in extracellular vesicles (EV) to facilitate cell-to-cell genetic communication. The purpose of this study was to characterize the baseline population of miRs secreted in EVs in the airways of young children (airway secretory microRNAome) and examine the changes during rhinovirus (RV) infection, the most common cause of asthma exacerbations and the most important early risk factor for the development of asthma beyond childhood.METHODS: Nasal airway secretions were obtained from children (≤3 yrs. old) during PCR-confirmed RV infections (n = 10) and age-matched controls (n = 10). Nasal EVs were isolated with polymer-based precipitation and global miR profiles generated using NanoString microarrays. We validated our in vivo airway secretory miR data in an in vitro airway epithelium model using apical secretions from primary human bronchial epithelial cells (HBEC) differentiated at air-liquid interface (ALI). Bioinformatics tools were used to determine the unified (nasal and bronchial) signature airway secretory miRNAome and changes during RV infection in children.RESULTS: Multiscale analysis identified four signature miRs comprising the baseline airway secretory miRNAome: hsa-miR-630, hsa-miR-302d-3p, hsa- miR-320e, hsa-miR-612. We identified hsa-miR-155 as the main change in the baseline miRNAome during RV infection in young children. We investigated the potential biological relevance of the airway secretion of hsa-mir-155 using in silico models derived from gene datasets of experimental in vivo human RV infection. These analyses confirmed that hsa-miR-155 targetome is an overrepresented pathway in the upper airways of individuals infected with RV.CONCLUSIONS: Comparative analysis of the airway secretory microRNAome in children indicates that RV infection is associated with airway secretion of EVs containing miR-155, which is predicted in silico to regulate antiviral immunity. Further characterization of the airway secretory microRNAome during health and disease may lead to completely new strategies to treat and monitor respiratory conditions in all ages.

MicroRNAs and the immune response to respiratory virus infections

Progress of the Stady on Microrna in Regulating Innate Immunity

microRNA-guided immunity against respiratory virus infection in human and mouse lung cells

Critical Role of Micrornas in Host and Influenza A (H1N1) Virus Interactions.

Airway Secretory microRNAome Changes during Rhinovirus Infection in Early Childhood

miRNAs and Leukotrienes in Respiratory Syncytial Virus Infection

RNA–RNA interactions between respiratory syncytial virus and miR-26 and miR-27 are associated with regulation of cell cycle and antiviral immunity

The Molecular Mechanisms of microRNA Regulating Innate Immune Response

Airway mir-155 responses are associated with TH1 cytokine polarization in young children with viral respiratory infections

MicroRNAs: Mediators and Therapeutic Targets to Airway Hyper Reactivity after Respiratory Syncytial Virus Infection

Role of microRNAs in inflammatory upper airway diseases

MicroRNAs: Small but Key Players in Viral Infections and Immune Responses to Viral Pathogens

MicroRNAs in Epithelial Antimicrobial Immunity

RNA-RNA interactions between Respiratory syncytial virus and miR-26 and miR-27 are associated with regulation of cell cycle and antiviral immunity

Potential Role of MicroRNAs in the Regulation of Antiviral Responses to Influenza Infection

Acute and Chronic Airway Responses to Viral Infection

Exosomal microRNA/miRNA Dysregulation in Respiratory Diseases: From Mycoplasma-Induced Respiratory Disease to COVID-19 and Beyond

Molecular Background of miRNA Role in Asthma and COPD: An Updated Insight

Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS‐CoV‐2 and other respiratory viruses: A comprehensive review

Bacterial small RNAs may mediate immune response differences seen in respiratory syncytial virus versus rhinovirus bronchiolitis

Micro-RNAs in the Regulation of Immune Response Against SARS CoV-2 and Other Viral Infections.